IO Biotech, Inc. (IOBT) Misses Q2 EPS by 3c

IO Biotech, Inc. (NASDAQ: IOBT) reported Q2 EPS of ($0.40), $0.03 worse than the analyst estimate of ($0.37).

For earnings history and earnings-related data on IO Biotech, Inc. (IOBT) click here.

You May Also Be Interested In

• LeonaBio (LONA) Price Target Cut to $17 by Citizens Amid Pipeline Development
• JPMorgan Downgrades JD Logistics Inc (2618:HK) (JDLGF) to Neutral
• Alpha's Drilling Confirms Second Target of Scale at Anagulu Copper-Gold Porphyry Project